Enriched in OLL; PVD; head mesodermal cell; oocyte; and sensory neurons based on microarray and RNA-seq studies. Is affected by several genes including
cyc-1;
etr-1; and
mrps-5 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eleven chemicals including metformin; Sirolimus; and silicon dioxide nanoparticle based on RNA-seq; microarray; and proteomic studies. Is predicted to encode a protein with the following domains: PDZ domain; FERM/acyl-CoA-binding protein superfamily; FERM N-terminal domain; Band 4.1 domain; FERM C-terminal PH-like domain; FERM, C-terminal PH-like domain; FERM, N-terminal; FERM superfamily, second domain; Non-receptor Tyrosine-protein Phosphatases; Ubiquitin-like domain superfamily; PDZ superfamily; FERM central domain; and PH-like domain superfamily. Is an ortholog of human FRMPD2 (FERM and PDZ domain containing 2). Human FRMPD2 enables 1-phosphatidylinositol binding activity.